Howard Streicher
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 43
- CAR-T cell therapy research 16
- Co-authors
- Cristina R. AntonescuWilliam D. TapSandra P. D’AngeloMohammed MilhemGary K. SchwartzMichelle R. MahoneyBrian Andrew Van TineElad Sharon
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Research (9 papers)Journal for ImmunoTherapy of Cancer (8 papers)Blood (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
Howard Streicher
95 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 1.8k
- Immunology 1.2k
- Biological Psychiatry 97
- Virology 138
- Pulmonary and Respiratory Medicine 760
Countries citing papers authored by Howard Streicher
This map shows the geographic impact of Howard Streicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Streicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Streicher more than expected).
Fields of papers citing papers by Howard Streicher
This network shows the impact of papers produced by Howard Streicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Streicher. The network helps show where Howard Streicher may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Streicher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 97 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 74 | |
| 15 | Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials Hit paper breakdown → | 2018 | 494 |
| 16 | 2018 | 36 | |
| 17 | 2016 | 98 | |
| 18 | 2016 | 78 | |
| 19 | 2015 | 234 | |
| 20 | 1987 | 3 |
About Howard Streicher
Howard Streicher is a scholar working on Oncology, Biological Psychiatry, Immunology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 105 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), CAR-T cell therapy research (16 papers), Immunotherapy and Immune Responses (12 papers), Lung Cancer Treatments and Mutations (8 papers), T-cell and Retrovirus Studies (8 papers), Cancer Genomics and Diagnostics (7 papers), Immune Cell Function and Interaction (6 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.2k citations), Biological Psychiatry (97 citations), Virology (138 citations) and Pulmonary and Respiratory Medicine (760 citations). Howard Streicher has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Cristina R. Antonescu, William D. Tap, Sandra P. D’Angelo, Mohammed Milhem, Gary K. Schwartz, Michelle R. Mahoney, Brian Andrew Van Tine, Elad Sharon, James N. Atkins and Balkrishna Jahagirdar. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.